Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The spiramycin paradox.

C R Smith1

  • 1Department of Epidemiology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

The Journal of Antimicrobial Chemotherapy
|July 1, 1988
PubMed
Summary
This summary is machine-generated.

Spiramycin demonstrates significant efficacy in infections, outperforming expectations based on its in-vitro activity. This enhanced effectiveness is attributed to superior tissue penetration and sustained concentrations, leading to improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Muscular dystrophy mimicking refractory idiopathic inflammatory myositis: a trio of cases.

Rheumatology (Oxford, England)·2007
Same author

An experimental study of competition between fire ants and Argentine ants in their native range.

Ecology·2007
Same author

Fetal cardiac calcifications: report of four prenatally diagnosed cases and review of the literature.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2006
Same author

Robotic mitral valve surgery: a United States multicenter trial.

The Journal of thoracic and cardiovascular surgery·2005
Same author

Increased rate of major malformations in offspring exposed to valproate during pregnancy.

Neurology·2005
Same author

Healing of unstented tubularized incised plate urethroplasty: an experimental study in a rabbit model.

BJU international·2003
Same journal

Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

The Journal of antimicrobial chemotherapy·2026
Same journal

Insights into the mechanisms underlying cell wall-active agents and gentamicin bactericidal synergism against Enterococcus faecalis.

The Journal of antimicrobial chemotherapy·2026
Same journal

Re-evaluating the 14-day rule: short-course antifungal therapy for uncomplicated candidaemia in a multicentre cohort study.

The Journal of antimicrobial chemotherapy·2026
Same journal

Impact of selective digestive decontamination on the pangenome composition of ESBL-E. coli.

The Journal of antimicrobial chemotherapy·2026
Same journal

Compounds of the γ-carboline family inhibit trans-translation.

The Journal of antimicrobial chemotherapy·2026
See all related articles

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Background:

  • Spiramycin exhibits modest in-vitro antimicrobial activity.
  • Clinical and experimental data suggest spiramycin is effective in various infections.

Purpose of the Study:

  • To investigate the reasons behind spiramycin's in-vivo efficacy despite its in-vitro limitations.
  • To compare spiramycin's effectiveness with erythromycin in animal infection models.

Main Methods:

  • Analysis of spiramycin's pharmacokinetic profile, focusing on tissue and intracellular concentrations.
  • Evaluation of post-antibiotic effect (PAE) and subinhibitory effects.

Main Results:

  • Spiramycin achieves intracellular and tissue concentrations 10-fold higher than serum levels.

Related Experiment Videos

  • Lower clearance rates from tissues result in sustained drug concentrations.
  • Spiramycin exhibits a significant post-antibiotic effect, potentially enhancing in-vivo activity.

    • Conclusions:

    • Spiramycin's in-vivo effectiveness is significantly influenced by its pharmacokinetic properties, including high tissue penetration and sustained release.
    • These factors, along with post-antibiotic effects, explain its therapeutic success beyond in-vitro susceptibility data.